Study of iStent and iDose for moderate to severe glaucoma
Part of Eyes & vision clinical trials.
This trial studies a new treatment (a tiny device called iStent Infinite and a medication implant) for people with moderate to severe open-angle glaucoma who have not responded well to drops or laser. The goal is to see if this treatment can lower eye pressure and help avoid traditional surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate or severe open-angle glaucoma (including certain types like primary open-angle, pigmentary, or pseudoexfoliation glaucoma).
- Your eye's drainage angle is open (normal anatomy).
- Your vision is at least hand motion (you can see movement).
- Your visual field test shows a specific pattern of vision loss (called MD -6 decibels or worse).
- You have tried eye drops or laser treatment, but they didn't work well enough, and your doctor is considering surgery next.
- You haven't had any previous glaucoma surgery that cuts into the eye (like a trabeculectomy or tube shunt).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new minimally-invasive surgery called MIMS to lower eye pressure in people with open-angle glaucoma that isn't well controlled even with multiple eye drop medications. The surgery makes a tiny opening to help fluid drain and reduce pressure in the eye.
This trial studies a tiny implant called iStent Infinite that helps drain fluid from the eye to lower pressure in people with mild to moderate open-angle glaucoma. It may offer a new way to manage the condition.
This trial tests a tiny implant that slowly releases travoprost (a pressure-lowering medicine) inside the eye, combined with a small stent (iStent) to help drain fluid. It's for people with open-angle glaucoma or high eye pressure who need to lower their eye pressure.
This trial tests a small stent to help drain fluid from the eye and lower pressure in people who have both open-angle glaucoma and cataracts. The stent is placed during routine cataract surgery.
This trial compares two treatment options for people with exfoliation glaucoma who also have cataracts: a tiny implant placed during cataract surgery (iStent) versus laser treatment. It aims to see which approach better controls eye pressure over 12 months and improves outcomes.
This study tests a tiny implant (iStent inject W) that helps lower eye pressure in people with open-angle glaucoma. A special contact lens sensor will monitor your eye pressure after surgery. The goal is to see how well the implant works and how it changes your eye pressure throughout the day.
Hear when a new Pigmentary Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.